MBX Biosciences, Inc.
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 242.43% | 224.94% | -- | -- | 65.60% |
| Total Receivables | 595.98% | 227.88% | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -26.56% | 49.18% | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 272.62% | 503.76% | -- | -- | -- |
| Total Current Assets | 236.02% | 220.24% | -- | -- | -- |
|
|
|||||
| Total Current Assets | 236.02% | 220.24% | -- | -- | -- |
| Net Property, Plant & Equipment | 81.82% | 80.30% | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -97.13% | 0.00% | -- | -- | -- |
| Total Assets | 226.51% | 219.00% | -- | -- | -- |
|
|
|||||
| Total Accounts Payable | 32.82% | 283.54% | -- | -- | -- |
| Total Accrued Expenses | 160.61% | 132.79% | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -17.20% | 11.76% | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 84.01% | 181.48% | -- | -- | -- |
|
|
|||||
| Total Current Liabilities | 84.01% | 181.48% | -- | -- | -- |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -87.57% | -78.35% | -- | -- | -- |
| Total Liabilities | 74.78% | 158.52% | -- | -- | -- |
|
|
|||||
| Common Stock & APIC | 8,036.87% | 12,826.09% | -- | -- | -- |
| Retained Earnings | -83.56% | -81.93% | -- | -- | -- |
| Treasury Stock & Other | 1,866.67% | -8.33% | -- | -- | -- |
| Total Common Equity | 383.48% | 455.25% | -- | -- | -94.92% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | 81.64% |
|
|
|||||
| Total Common Equity | 383.48% | 455.25% | -- | -- | -94.92% |
| Total Preferred Equity | -- | -- | -- | -- | 81.64% |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 239.67% | 222.25% | -- | -- | 67.93% |
|
|
|||||